PRI's Focus on Health Care

View this email in your browser ([link removed])
Biden a moderate? Sanders, AOC plans for candidate suggest this instead

Fox News | Sally C. Pipes
July 19, 2020

Perhaps that shouldn’t be surprising. One of the primary purposes of the unity task forces was to line up the base support of Sen. Bernie Sanders, I-Vt., behind Biden. To do so, the former vice president gave Sanders and several of his acolytes, including Rep. Alexandria Ocasio-Cortez, D- N.Y., prominent roles on the project.
Read more. . . ([link removed])

Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
Forbes | Wayne Winegarden
July 20, 2020

The idea is called reference pricing. While there are many ways that politicians try to implement it, essentially reference pricing mandates that the price of drugs in the U.S. equal the average price charged in a set of reference countries. Typically, the reference countries are the ones that impose the most stringent price controls. As a result, adopting reference pricing is a way for the Trump Administration to impose price controls on U.S. pharmaceuticals without having to take responsibility for the decision.
Read more. . . ([link removed])

Medicaid Expansion Will Add To Oklahoma’s Woes
Forbes | Sally C. Pipes
July 20, 2020

Medicaid expansion seems like a great deal for states. The federal government picks up 90% of the tab for new enrollees. Given how badly the coronavirus pandemic has battered state budgets and undermined public health, a massive influx of federal healthcare dollars would appear to be a huge help.
Read more. . . ([link removed])

Dr. Henry Miller Talk COVID-19 Vaccines, Herd Immunity on the John Batchelor Show
The John Batchelor Show | Henry Miller, M.S., M.D.
July 14, 2020

Batchelor and Miller also talk about the latest progress with a potential vaccine, including the start of production, and the selections by the Trump administration for the most promising vaccines, and the average effectiveness for vaccines set by the FDA.
Listen here. . . ([link removed])
[link removed]
The Affordability Problem ([link removed])
PRI | Drug Pricing Video Series
July 15, 2020
The Professor and Pete go to the movies to learn why there is a drug affordability problem. After watching a scary thriller about list prices and net prices, an adventure on the prescription escalator, and a movie on biosimilars, they learn that a) specific patient populations are impacted by the drug affordability problem; and b) these issues can be fixed with targeted reforms to achieve innovation and affordability.

Click here to watch. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.